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DrK. Craig Kent (New York, NY). Is this something that the
average vascular surgeon can ever accomplish, or is this a procedure
that is going to be taken care of in selective institutions around the
world?
Dr Roy Greenberg. Well, I think that thoracoabdominal
aneurysm repair is something that is done in centers with a lot of
expertise. But I think that the actual technical requirements of
doing a branched endograft are not that different than an open
aneurysm repair, once you understand the principles.
Much like the presentation from Japan, where they have
struggled with how to train someone to size an arch device, with all
these complex branches, it requires knowledge, time, and under-
standing. They have a single individual to size all devices, while we
prefer that the individual treating physician design each device. WeHow can we put it in the hands of everyone to say, okay, you want
a branch device, here is how you design it. This is in the form of a
computer program involving mathematical modeling. This was
recently published in JVS (Journal of Vascular Surgery) and by
IEEE (Institute of Electrical and Electronics Engineers) and it
allows the physician to determine the proximal extent of the repair
and then determines the geometric configuration of the specified
branches. This allows for a semi-automated design.
Critically, it is the treating physician that is still making the
decisions. This is a really important thing. It allows clinicians
develop judgment based on who does well with different designs,
and the amount of the aorta that can be repaired safely in a given
patient and the extent of the repair. You can’t send your films off to
someone else and say design me a device, without any context of
the patient and the other comorbidities.
